These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 30633040

  • 1. Young Women's Stated Preferences for Biomedical HIV Prevention: Results of a Discrete Choice Experiment in Kenya and South Africa.
    Minnis AM, Browne EN, Boeri M, Agot K, van der Straten A, Ahmed K, Weinrib R, Mansfield C.
    J Acquir Immune Defic Syndr; 2019 Apr 01; 80(4):394-403. PubMed ID: 30633040
    [Abstract] [Full Text] [Related]

  • 2. Young Women's Ratings of Three Placebo Multipurpose Prevention Technologies for HIV and Pregnancy Prevention in a Randomized, Cross-Over Study in Kenya and South Africa.
    Minnis AM, Roberts ST, Agot K, Weinrib R, Ahmed K, Manenzhe K, Owino F, van der Straten A, TRIO Study Team.
    AIDS Behav; 2018 Aug 01; 22(8):2662-2673. PubMed ID: 29560570
    [Abstract] [Full Text] [Related]

  • 3. Insights for Implementation Science From 2 Multiphased Studies With End-Users of Potential Multipurpose Prevention Technology and HIV Prevention Products.
    Minnis AM, Montgomery ET, Napierala S, Browne EN, van der Straten A.
    J Acquir Immune Defic Syndr; 2019 Dec 01; 82 Suppl 3():S222-S229. PubMed ID: 31764258
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Preferences for long-acting Pre-Exposure Prophylaxis (PrEP) for HIV prevention among South African youth: results of a discrete choice experiment.
    Minnis AM, Atujuna M, Browne EN, Ndwayana S, Hartmann M, Sindelo S, Ngcwayi N, Boeri M, Mansfield C, Bekker LG, Montgomery ET.
    J Int AIDS Soc; 2020 Jun 01; 23(6):e25528. PubMed ID: 32544303
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Female and male partner perspectives on placebo Multipurpose Prevention Technologies (MPTs) used by women in the TRIO study in South Africa and Kenya.
    Wagner LD, Minnis AM, Shea J, Agot K, Ahmed K, van der Straten A.
    PLoS One; 2022 Jun 01; 17(5):e0265303. PubMed ID: 35551318
    [Abstract] [Full Text] [Related]

  • 13. "We are not the same": African women's view of multipurpose prevention products in the TRIO clinical study.
    Shapley-Quinn MK, Manenzhe KN, Agot K, Minnis AM, van der Straten A.
    Int J Womens Health; 2019 Jun 01; 11():97-107. PubMed ID: 30799959
    [Abstract] [Full Text] [Related]

  • 14. Giving voice to the end-user: input on multipurpose prevention technologies from the perspectives of young women in Kenya and South Africa.
    Minnis AM, Krogstad E, Shapley-Quinn MK, Agot K, Ahmed K, Danielle Wagner L, van der Straten A, TRIO Study Team.
    Sex Reprod Health Matters; 2021 Dec 01; 29(1):1927477. PubMed ID: 34224341
    [Abstract] [Full Text] [Related]

  • 15. HIV prevention is not all about HIV - using a discrete choice experiment among women to model how the uptake and effectiveness of HIV prevention products may also rely on pregnancy and STI protection.
    Vickerman P, Quaife M, Kilbourne-Brook M, Mvundura M, Eakle R, Terris-Prestholt F.
    BMC Infect Dis; 2020 Sep 25; 20(1):704. PubMed ID: 32977745
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Stated preferences for new HIV prevention technologies among men who have sex with men in India: A discrete choice experiment.
    Cameron MP, Newman PA, Chakrapani V, Shunmugam M, Roungprakhon S, Rawat S, Baruah D, Nelson R, Tepjan S, Scarpa R.
    PLoS One; 2024 Sep 25; 19(7):e0289396. PubMed ID: 39046999
    [Abstract] [Full Text] [Related]

  • 20. End-user preference for and choice of four vaginally delivered HIV prevention methods among young women in South Africa and Zimbabwe: the Quatro Clinical Crossover Study.
    Montgomery ET, Beksinska M, Mgodi N, Schwartz J, Weinrib R, Browne EN, Mphili N, Musara P, Jaggernath M, Ju S, Smit J, Chirenje ZM, Doncel GF, van der Straten A.
    J Int AIDS Soc; 2019 May 25; 22(5):e25283. PubMed ID: 31069957
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.